IBM Big Data Hub
AUGUST 7, 2023
This article, part of the IBM and Pfizer’s series on the application of AI techniques to improve clinical trial performance, focuses on enrollment and real-time forecasting. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.
HL Chronicle of Data Protection
MARCH 5, 2020
For example, a public administration targeting specific groups susceptible to specific diseases does not engage in direct marketing unless a specific medicinal product and/or pharmaceutical company is mentioned. How to Comply? The Recommendation provides a step-by-step approach on how achieve compliance: 1. Necessity for Data Minimisation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Preservica
OCTOBER 30, 2017
The GDPR article 28 states controllers "shall use only processors providing sufficient guarantees to (.) meet the requirements of this Regulation", so your choice of vendor(s) is critical to meeting your own obligations. First of all, the cloud. Now to digital preservation.
DLA Piper Privacy Matters
JANUARY 11, 2021
In the NIS Directive, the obligations that apply to an entity that falls under the scope of the NIS Directive depend on its qualification as ‘operator of essential services’ (“OES”) or ‘digital service provider’ (“DSP”): An OES is defined as a public or private entity of a type referred to in Annex II, which meets certain criteria.
DLA Piper Privacy Matters
OCTOBER 16, 2019
Article 47 GDPR lays down several criteria that BCRs need to meet in order to be approved by a supervisory authority. When looking at the lists of groups that have adopted BCRs, it is clear that most operate in highly regulated sectors, such as financial services, pharmaceutical or energy, or in the technology services industry.
Hunton Privacy
MARCH 23, 2010
The agents had been authorized by a lower court judge to inspect the emails pursuant to an investigation into an alleged abuse of dominant position in the pharmaceutical market. 450-4 of the French Code of Commerce authorizes Competition Authority agents to seize any documents that are relevant to their investigation.
CGI
SEPTEMBER 6, 2017
There are some powerful articles in the press about the impact of IA such as the ability for IA to enable pharmaceutical companies to produce cancer combatting drugs in 7 years rather than 15. So what evidence is there that this re-imagined world will be realised?
Expert insights. Personalized for you.
60 
Let's personalize your content